SCHEMBL20737178

SCHEMBL20737178

c1ccc(-c2cccc(-c3ccccc3-c3ccc4cc5c(cc4c3)C3(c4ccccc4-c4ccccc43)c3cc4ccccc4cc3-5)n2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
LMNA P02545 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
CCR1 P32246 3/20 0.43
CCR5 P51681 3/20 0.43
CCR8 P51685 3/20 0.43
TP53 P04637 2/20 0.43
ALPL P05186 1/20 0.43
HSP90AA1 P07900 1/20 0.43
ALPI P09923 1/20 0.43
ALPG P10696 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PDK2 Q15119 1/20 0.43
MAPT P10636 2/20 0.39
PKM P14618 2/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735879 0.93 PDK2 (0.47) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL20735880 0.91 KDM4E (0.43) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL20736669 0.90 PDK2 (0.40) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL20737127 0.90 PDK2 (0.37) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL20737159 0.89 PDK2 (0.44) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL20737681 0.89 PDK2 (0.41) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL27250618 0.87 PDK2 (0.43) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL20736431 0.86 PDK2 (0.48) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL20735864 0.86 PDK2 (0.38) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL27250617 0.86 PDK2 (0.43) KDM4ELMNASMN1; SMN2CCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885LMNA 1778/4885SMN1; SMN2 1059/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 KDM4E 2169/4885LMNA 1778/4885SMN1; SMN2 1059/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885LMNA 1778/4885SMN1; SMN2 1059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.